Results 121 to 130 of about 1,194 (166)

Bioequivalence evaluation of generic febuxostat versus Feburic^® in healthy Chinese subjects: a randomized crossover study. [PDF]

BMC Pharmacol Toxicol
Wang F, Ye X, Li F, Kong H, Liao M, Kan M, Zhuang J, Wang A, Meng X.   +8 more
europepmc   +1 more source

Multiple gouty tophi in a six-year-old. [PDF]

Ghana Med J
Adefokun IG, Ano-Edward GH, Adesina SA, Uduagbamen PK, Eyesan SU.   +4 more
europepmc   +1 more source

Evaluation of treatment compliance in gout patients: a patient-centered study. [PDF]

Turk J Med Sci
Görgülü MB, Kardaş RC, Şeramet DK, Mercan R, Tezcan ME, Tufan A, Küçük H, Göker B, Öztürk MA.   +8 more
europepmc   +1 more source

Recurrent Gout and Serum Urate-Reply. [PDF]

JAMA
McCormick N, Choi HK.
europepmc   +1 more source

Analysis of the efficacy of multidisciplinary integration based on 3D reconstruction technology for the treatment of gout stone. [PDF]

J Orthop Surg Res
Zhou S, Zhang Z, Liu T, Xu Y, Pan Y, Chen Y.   +5 more
europepmc   +1 more source

Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden. [PDF]

BMJ Open
Drivelegka P, Jacobsson L, Sandström TZ, Lindström U, Bengtsson K, Dehlin M.   +5 more
europepmc   +1 more source

Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study. [PDF]

Arthritis Res Ther
Jun JB, Lee HS, Kim SH, Lee SG, Lim DH, Kim J, Park YB, Lim MJ, Hong SJ, Choi HJ, Lee SS, Kim HA, Hwang J, Suh CH, Han S, Choe JY, Yoo WH, Song JS.   +17 more
europepmc   +1 more source

Effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1, and oxidative stress in patients with a gout-a comparative study. [PDF]

Afr Health Sci
Tie N, Bai L, Li H, Man D, Wang L, Zhou X, Wang Y.   +6 more
europepmc   +1 more source

HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US.

JAMA Dermatol
Campbell CN, Krantz MS, Yu A, Phillips EJ, Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Survivor Study Collaborators.   +4 more
europepmc   +1 more source

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease.

JAMA Intern Med
Wang Y, Dalbeth N, Terkeltaub R, Zhang Y, Li X, Zeng C, Lei G, Wei J.   +7 more
europepmc   +1 more source